Agilent Technologies 미래 성장

Future 기준 확인 2/6

Agilent Technologies (는) 각각 연간 9.2% 및 5.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 23.3% 로 예상됩니다.

주요 정보

9.2%

수익 성장률

10.7%

EPS 성장률

Life Sciences 수익 성장	15.9%
매출 성장률	5.5%
향후 자기자본 수익률	23.3%
애널리스트 커버리지	Good
마지막 업데이트	21 Apr 2025

최근 미래 성장 업데이트

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Nov 28

Recent updates

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Apr 24

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Nov 28

Agilent Q4: Expecting Market Recovery In 2025

Nov 26

Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 26

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Oct 21

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Sep 23

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09

Strategic Expansion And Digital Innovation Poised To Catapult Growth In Life Sciences

Aug 29 Strategic acquisitions and innovation in biopharma and environmental testing highlight a focus on high-demand areas and regulatory changes, suggesting potential revenue growth.

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Aug 23

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Aug 14

Agilent: Making A Move To Ignite Some Growth

Jul 25

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Jul 15

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

May 23

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

May 22

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

May 07

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

수익 및 매출 성장 예측

NYSE:A - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
10/31/2027	7,572	1,697	1,769	2,114	11
10/31/2026	7,138	1,499	1,488	1,908	18
10/31/2025	6,729	1,400	1,207	1,729	17
1/31/2025	6,533	1,259	1,312	1,697	N/A
10/31/2024	6,510	1,289	1,373	1,751	N/A
7/31/2024	6,497	1,413	1,417	1,786	N/A
4/30/2024	6,591	1,242	1,538	1,896	N/A
1/31/2024	6,735	1,236	1,649	1,961	N/A
10/31/2023	6,833	1,240	1,474	1,772	N/A
7/31/2023	6,994	1,133	1,420	1,704	N/A
4/30/2023	7,040	1,351	1,183	1,468	N/A
1/31/2023	6,930	1,323	1,061	1,353	N/A
10/31/2022	6,848	1,254	1,021	1,312	N/A
7/31/2022	6,659	1,328	1,022	1,305	N/A
4/30/2022	6,527	1,263	1,058	1,313	N/A
1/31/2022	6,445	1,205	1,280	1,502	N/A
10/31/2021	6,319	1,210	1,297	1,485	N/A
7/31/2021	6,142	990	1,268	1,421	N/A
4/30/2021	5,817	925	1,253	1,377	N/A
1/31/2021	5,530	810	1,092	1,218	N/A
10/31/2020	5,339	719	802	921	N/A
7/31/2020	5,223	691	736	858	N/A
4/30/2020	5,236	683	665	810	N/A
1/31/2020	5,236	764	598	749	N/A
10/31/2019	5,163	1,071	865	1,021	N/A
7/31/2019	5,090	1,072	917	1,079	N/A
4/30/2019	5,019	1,117	887	1,034	N/A
1/31/2019	4,987	1,140	929	1,085	N/A
10/31/2018	4,914	316	N/A	1,087	N/A
7/31/2018	4,809	298	N/A	1,003	N/A
4/30/2018	4,720	237	N/A	1,034	N/A
1/31/2018	4,616	196	N/A	988	N/A
10/31/2017	4,472	684	N/A	889	N/A
7/31/2017	4,394	633	N/A	835	N/A
4/30/2017	4,324	582	N/A	801	N/A
1/31/2017	4,241	509	N/A	798	N/A
10/31/2016	4,202	462	N/A	793	N/A
7/31/2016	4,126	476	N/A	800	N/A
4/30/2016	4,096	465	N/A	714	N/A
1/31/2016	4,040	466	N/A	643	N/A
10/31/2015	4,038	438	N/A	1,322	N/A
7/31/2015	4,046	306	N/A	1,245	N/A
4/30/2015	4,041	256	N/A	1,165	N/A
1/31/2015	4,066	204	N/A	1,307	N/A
10/31/2014	4,048	232	N/A	731	N/A
7/31/2014	4,723	435	N/A	924	N/A
4/30/2014	5,366	540	N/A	1,111	N/A

애널리스트 미래 성장 예측

수입 대 저축률: A 의 연간 예상 수익 증가율( 9.2% )이 saving rate( 2.8% 보다 높습니다. ).

수익 vs 시장: A 의 연간 수익( 9.2% ) US 시장( 14.1% 보다 느리게 성장할 것으로 예상됩니다. 14.1% 연간).

고성장 수익: A 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: A 의 수익(연간 5.5% ) US 시장( 8.1% 보다 느리게 성장할 것으로 예상됩니다. 8.1% 연간).

고성장 수익: A 의 수익(연간 5.5% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: A 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 23.3 %)

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/04/23 18:19
장 마감 주가	2025/04/23 00:00
수익	2025/01/31
연간 수익	2024/10/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

Agilent Technologies, Inc. 43 애널리스트 중 18 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
James Francis Mainwaring	Atlantic Equities LLP
Catherine Ramsey Schulte	Baird
Ishan Majumdar	Baptista Research

Agilent Technologies 미래 성장

Future 기준 확인 2/6

주요 정보

최근 미래 성장 업데이트

Agilent Technologies, Inc. Provides Earnings Guidance for the Fiscal Second Quarter and Full Year of 2025

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Price target decreased by 7.2% to US$140

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

Recent updates

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Tariffs And Tactics: Agilent's Path Through Trade Disruption

Agilent Technologies, Inc. Announces Resignation of Heidi Kunz as Member of the Board of Directors, Member of the Compensation Committee, and A Member of the Nominating/Corporate Governance Committee, Effective May 21, 2025

Upcoming dividend of US$0.25 per share

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Now 20% undervalued after recent price drop

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Now 20% undervalued after recent price drop

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

First quarter 2025 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. Provides Earnings Guidance for the Fiscal Second Quarter and Full Year of 2025

Getting In Cheap On Agilent Technologies, Inc. (NYSE:A) Is Unlikely

Fourth quarter dividend of US$0.25 announced

Agilent Announces Quarterly Cash Dividend, Payable on April 23, 2025

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. to Report Q1, 2025 Results on Feb 26, 2025

Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?

Agilent Technologies, Inc., Annual General Meeting, Mar 13, 2025

Upcoming dividend of US$0.25 per share

Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Insufficient new directors

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Agilent Q4: Expecting Market Recovery In 2025

Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025

Third quarter dividend increased to US$0.25

Agilent Technologies, Inc. Increases Quarterly Cash Dividend, Payable on January 22, 2025

Agilent Technologies, Inc. Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024

Insider notifies of intention to sell stock

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Third quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Strategic Expansion And Digital Innovation Poised To Catapult Growth In Life Sciences

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. Receives FDA Approval for Mage-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent Technologies, Inc. (NYSE:A) acquired Sigsense Technologies, Inc.

Agilent: Making A Move To Ignite Some Growth

Agilent Technologies, Inc. Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit

Agilent Technologies, Inc. to Report Q3, 2024 Results on Aug 21, 2024

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index

Now 20% undervalued after recent price drop

Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary

Insider recently sold US$2.0m worth of stock

Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics

Price target decreased by 7.2% to US$140

Second quarter 2024 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

First quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency